Injectable Drugs Market, By Molecule Type (Small Molecule and Large Molecule), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases

Injectable Drugs Market, By Molecule Type (Small Molecule and Large Molecule), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Endocrinology, Neurology, Others), By Drug Class (Monoclonal Antibodies, Peptides and Proteins, Small Molecules, Immunoglobulins, Hormones, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.

Market Dynamics:

Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.

Key features of the study:
  • This report provides in-depth analysis of the global injectable drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global injectable drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market
Detailed Segmentation-
  • By Molecule Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Small Molecule
  • Large Molecule
  • By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others (Intradermal etc.)
  • By Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Endocrinology
  • Neurology
  • Others (Respiratory, Hematology, etc.)
  • By Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
  • Monoclonal Antibodies
  • Peptides and Proteins
  • Small Molecules
  • Immunoglobulins
  • Hormones
  • Others (Vaccines, Biologics, etc.)
  • By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • Merck & Co., Inc.
  • Viatris + Mylan N.V
  • Cipla Inc.
  • Dr Reddy’s Laboratories Ltd.
  • Samsung Biologics
  • Abbott Laboratories
  • Amgen Incorporated
  • Baxter International Incorporated
  • Becton Dickinson and Company
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Roche Holding Limited


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Injectable Drugs Market, By Molecule Type
Global Injectable Drugs Market, By Route of Administration
Global Injectable Drugs Market, By Therapeutic Area
Global Injectable Drugs Market, By Drug Class
Global Injectable Drugs Market, By Distribution Channel
Global Injectable Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Injectable Drugs Market, By Molecule Type, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Small Molecule
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Molecule
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Injectable Drugs Market, By Route of Administration, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Intradermal etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Injectable Drugs Market, By Therapeutic Area, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Respiratory, Hematology, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Injectable Drugs Market, By Drug Class, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptides and Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Small Molecules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunoglobulins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hormones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Vaccines, Biologics, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Injectable Drugs Market, By Distribution Channel, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Injectable Drugs Market, By Region, 2019 - 2031, (USD Bn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
Market Y-o-Y Growth Analysis (%), 2020- 2031, (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Molecule Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Therapeutic Area, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
AstraZeneca Plc
Merck & Co., Inc.
Viatris + Mylan N.V
Cipla Inc.
Dr Reddy’s Laboratories Ltd.
Samsung Biologics
Abbott Laboratories
Amgen Incorporated
Baxter International Incorporated
Becton Dickinson and Company
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Roche Holding Limited
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ' Injectable Drugs Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings